Dec 26, 2019
Today we continue our 2019
NeurIPS coverage joined by Daphne Koller, co-Founder and former
co-CEO of Coursera and Founder and CEO of Insitro. We caught up
with Daphne to discuss:
background in machine learning, beginning in ‘93, and her work with
the Stanford online machine learning courses, and eventually her
work at Coursera.
current landscape of pharmaceutical drug discovery, including the
current pricing of drugs and misnomers with why drugs are so
work at Insitro, a company looking to advance drug discovery and
development with machine learning.
overview of Insitro’s goal of using ML as a “compass” in drug
Insitro functions as a company in this space, including their focus
on the biology of drug discovery and the landscape of ML techniques
- Daphne’s thoughts on AutoML, and much
The full show notes for this
episode can be found at twimlai.com/talk/332. Make sure
you head over to twimlai.com/neurips2019 to
follow along with this series!